![]() government sparked Novamind’s interest to increase their investment.Īnother reason for the increased investment is the clinical trial of BNC210. Not all potential treatments receive fast track designations, especially when it comes from the FDA. Recently, Bionomics’ drug for treating PTSD received a Fast Track Designation from the U.S. Novamind originally invested in Bionomics and increased their investment because of BNC210. Why Novamind is Interested in What Bionomics Offers It is a drug currently in development for the treatment of PTSD (post traumatic stress disorder). They utilize their proprietary technology to discover and develop novel drug candidates.Ĭurrently, Bionomics’ most promising candidate is BNC210. Bionomics is a global, clinical biopharmaceutical company. These treatments can be found through Novamind’s network of Cedar Psychiatry clinics and the work done by Cedar Clinical Research. They provide a number of novel treatments, such as ketamine-assisted psychotherapy. Their goal is to enable safe access to psychedelic medicine through an expansive network of clinics, retreats, and r esearch sites. Novamind and Bionomics: Who They AreĪs a business, Novamind is a mental health company. At this point, Novamind has invested almost a million dollars into Bionomics stock, totaling $965,400. Novamind initially invested $827,486 in Bionomics back in February of 2021. However, this is not the first time that Novamind has invested in Bionomics. dollars or around 132,000 Canadian dollars. This new investment totals at 137,914 U.S. Novamind acquired an additional 951,133 shares of Bionomics at $0.145 per share. ( NVMDF) announced that it has increased their strategic investment in Bionomics ( BNOEF). Now, a new deal between mental health company Novamind and biopharmaceutical company Bionomics could present a great opportunity for investors. New laws and adaptable companies contribute the most to these shifts. For investors in psychedelics or cannabis stocks, the market is constantly changing.
0 Comments
Leave a Reply. |